Telik

Telik, Inc. was set up in 1988 and was reverse merged into privately held MabVax in May 2014.^[1] The major drug of the company was TELINTRA, an investigational agent that was in development for the treatment of myelodysplastic syndrome (MDS) and idiopathic chronic neutropenia.^[2]

Telik Inc

Industry	Healthcare, Drug Manufacturers - Other
Founded	1988
Headquarters	Palo Alto, California , United States
Key people	Michael M. Wick M.D. ( Chairman, Chief Executive Officer, and President) Wendy K. Wee ( Principal Financial & Accounting Officer ) Gail L. Brown M.D. ( Chief Medical Officer ) (Dec 31, 2012)
Number of employees	17 (Dec 31, 2012)
Website	telik.com

Controversies

In 2007, a class action was filed against Telik, Inc., alleging that they made false and misleading statements about the Company’s business and prospects during the Class Period.^[3]